These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37256932)

  • 1. lncRNA PCBP1-AS1 mediated downregulation of ITGAL as a prognostic biomarker in lung adenocarcinoma.
    Wang Q; Xiao G; Li N; Jiang X; Li C
    Aging (Albany NY); 2023 May; 15(10):4510-4523. PubMed ID: 37256932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.
    Zhang R; Zhu G; Li Z; Meng Z; Huang H; Ding C; Wang Y; Chen C; Li Y; Liu H; Chen J
    Front Immunol; 2024; 15():1382231. PubMed ID: 38646528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis highlights the significance role of ITGAL in lung adenocarcinoma.
    Xiao Z; Nian Z; Zhang M; Liu Z; Liu Z; Zhang Z
    J Cell Mol Med; 2024 Apr; 28(8):e18289. PubMed ID: 38613346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
    Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.
    Sun J; Zhang Z; Bao S; Yan C; Hou P; Wu N; Su J; Xu L; Zhou M
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32041817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
    Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
    Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma.
    Wang L; Zhou SQ; Zhou Y; Lu JX
    J Immunol Res; 2022; 2022():8069858. PubMed ID: 35600050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.
    Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ
    Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
    Yu Z; Wang G; Zhang C; Liu Y; Chen W; Wang H; Liu H
    Cell Cycle; 2020 Feb; 19(3):300-316. PubMed ID: 31928130
    [No Abstract]   [Full Text] [Related]  

  • 10. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
    Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
    Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC.
    Li X; Zhang X; Yang C; Cui S; Shen Q; Xu S
    Cell Cycle; 2018; 17(14):1772-1783. PubMed ID: 30010468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
    Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
    Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
    Li Q; Jiang B; Qi Y; Zhang H; Ma H
    Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
    Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
    Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
    Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
    Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
    Zhou X; Wang N; Zhang Y; Yu H; Wu Q
    Invest New Drugs; 2022 Feb; 40(1):43-57. PubMed ID: 34499335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
    Song H; Li H; Ding X; Li M; Shen H; Li Y; Zhang X; Xing L
    Int J Oncol; 2020 Dec; 57(6):1333-1347. PubMed ID: 33174014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.